1 Home > 2 Business Areas > 3 Specific projects for an affordable healthcare system

Johnson & Johnson presents specific projects for an affordable healthcare system

Johnson & Johnson realizes, together with Swiss hospitals, specific projects for value-based healthcare (VBHC). These projects make it possible to have better outcomes at the same or even lower costs.

At an event in Bern, Johnson & Johnson presented its initial findings, together with the private clinic group Swiss Medical Network (SMN), the Biel Hospital Center and the consulting firm PwC.
Around 30 representatives from health authorities, hospitals, politics, associations and the media attended the event.

“Johnson & Johnson’s value-based healthcare programs are designed to provide patients with better-quality care and to combat negative financial developments in the healthcare sector,” said Roman Iselin at the opening of the event in Bern. The country head of Johnson & Johnson Medical Devices in Switzerland emphasized the close collaboration of the healthcare company with partners: “It’s absolutely crucial to work in cooperation so that value-based healthcare can revolutionize the healthcare system.”

Faster recovery times and more satisfied patients
Together with partners, Johnson & Johnson has launched patient pathway programs. As part of its Triple Aim approach, the company wants to optimize the outcome of medical treatments, improve the patient experience and reduce costs. The experiences that Swiss hospitals have had with the programs are promising. The duration of a hospital stay during hip and knee operations at the SMN Clinic La Providence in Neuchâtel has been reduced by up to 40% due to the faster recovery and mobilization of patients. This leads to significant cost savings. At the same time, patient satisfaction has increased.

Prof. Guido Garavaglia, specialist in orthopedics and traumatology of the musculoskeletal system at the SMN Clinic Ars Medica in Gravesano, emphasized the importance of the implant register: “In orthopedics it has become an indispensable instrument for assessing the quality of implants and treatment. SIRIS, the Swiss Implant Registry, plans to introduce PROMS (Patient Reported Outcome Measures) in the near future. This is an important step forward, because PROMS is not only used to measure the quality of treatment, but it also serves as a direct educational aid for the patient.”

The Biel Hospital Center has also had very positive experiences with VBHC programs: “The standardization of processes has led to a significant reduction in misunderstandings among the persons working in the operating theater. This has also helped to reduce the duration of an operation. For patients, this means that the length of time that they will have to be anaesthetized is reduced, and for us as a hospital, it means that we will have additional capacity. Experience has shown that our patients are more satisfied with their treatment, recover faster and return to work sooner,” said Kristian Schneider, CEO of the Biel Hospital Center.

“Value-based healthcare will change the healthcare sector over the long run,” said Patrick Schwendener, Head of Deals Healthcare at PwC Switzerland. Long-term solutions and multi-lateral partnerships are crucial for this. Outcomes are to be as standardized as possible and should be accessible. Long-term VBHC concepts are scalable and can be commercialized. “In the end, the compensation incentives are set in such a way that all stakeholders strive for higher quality at the same or lower costs.

Johnson & Johnson (Corporate) | www.jnj.com